Historical note and clinical description of gelastic seizures
=============================================================

Laughing seizures were first described by [@b93-ndt-4-1021]. Trousseau described a patient that had a seizure in a regular clinic visit characterized by vertigo and jerking bursts of laughter. When Trousseau asked the patient why he laughed, the patient was surprised with the question because he was not aware during the spell. Trousseau used the term epileptic vertigo for any 'transient strange phenomena -- giddiness, astonishment, ecstasy ... fit of absence', which he regarded as 'identical in nature with violent convulsions'. Some years later [@b32-ndt-4-1021] observed emotions with a cheerful character as a part of a seizure. [@b13-ndt-4-1021] coined the term "gelastic epilepsy" in 1957. The term comes from the Greek word "gelos" (laughter), to emphasize the main characteristic of these seizures. [@b30-ndt-4-1021] proposed some criteria for gelastic epilepsy including stereotyped recurrence, absence of external precipitants, concomitant manifestations accepted as epileptic, presence of interictal electroencephalography (EEG) abnormalities and absence of conditions that can cause pathologic laughter. [@b30-ndt-4-1021] also suggested the importance of diencephalic lesions in many cases as a cause of the gelastic seizures (GS).

GS are epileptic events characterized by bouts of laughter ([@b30-ndt-4-1021]). Laughter-like vocalization is usually combined with facial contraction in the form of a smile ([@b65-ndt-4-1021]). Autonomic features such as tachycardia, flushing, and altered respiration are widely recognized ([@b11-ndt-4-1021]). Conscious state may not be impaired, although this is often difficult to asses particularly in young children. Mirth sensation during GS is not frequent and many adults report more commonly an unpleasant epigastric sensation ([@b87-ndt-4-1021]). Some patients describe an urge to laugh that sometimes can be suppressed ([@b90-ndt-4-1021]). GS are rarely diagnosed at onset. They may be mistaken by normal laughter or misdiagnosed as infantile colic ([@b66-ndt-4-1021]; [@b92-ndt-4-1021]). The complexity of the diagnosis is based on the fact that ictal and interictal EEG usually are normal or with nonspecific findings. Some patients can have coexistence of gelastic and dacrystic seizures. Dacrystic seizures (DS) were described by [@b85-ndt-4-1021]. Dacrystic episodes can present in clusters at sleep onset, some patients can moan at the onset, with face-flushing that rapidly evolves into crying, associated with facial oro-alimentary automatisms ([@b46-ndt-4-1021]).

Localization of gelastic seizures
=================================

GS have been related classically with hypothalamic hamartomas (HHs), although several descriptions have mentioned other locations ([@b33-ndt-4-1021]). [@b51-ndt-4-1021] reported a case of a patient with GS originated over the anterior cingulate region. The seizure onset was demonstrated with EEG and magnetoencephalography (MEG) and the patient became seizure-free after resection. Other cases in the cingulate region have been described before ([@b50-ndt-4-1021]). Some reports have described GS with frontal onset. [@b81-ndt-4-1021] reported a young patient with GS, where the frontal seizure onset was demonstrated by conventional EEG and single photon emission computed tomography (SPECT). This patient did not have a HH and was successfully treated with medication. [@b28-ndt-4-1021] reported another case with frontal onset in a three-and-a-half-year-old baby who was successfully treated with viga-batrin. The focal origin was demonstrated with scalp EEG and the magnetic resonance imaging (MRI) did not show a HH. [@b86-ndt-4-1021] described another case where the seizure onset was localized in the parietal area. Finally some authors have presented convincing reports of GS from the temporal area. [@b18-ndt-4-1021] reported a patient with GS associated with an area of cortical dysplasia over the right temporal area. Interictal and ictal EEG were concordant with the lesion demonstrated in the MRI. The patient had a temporal lobectomy and became seizure free. On the other hand, the localization for dacrystic seizures is similar to patients with GS. Reports of patients with coexistence of both types of seizures are associated with HHs ([@b46-ndt-4-1021]), although ([@b38-ndt-4-1021]) some reports have described dacrystic seizures in patients with temporal epilepsy ([@b15-ndt-4-1021]; [@b14-ndt-4-1021]).

Syndrome of hypothalamic hamartoma and gelastic seizures
========================================================

GS are almost always the first seizure manifestation of HH. Only rarely other types of seizures are the first presentation of HH. GS start in infancy in over one third of patients ([@b48-ndt-4-1021]). Neonatal onset of seizures is widely reported, as early as the first day ([@b41-ndt-4-1021]). GS usually occur with high frequency and periodicity, especially in children.

The natural history of children who present with early onset of GS is the progression to intractable epilepsy ([@b6-ndt-4-1021]). Typically this occurs between the ages of 4 to 10 years and involves the presence of multiple types of seizures, including complex partial seizures with or without secondary generalization, generalized tonic-clonic seizures and drop attacks ([@b9-ndt-4-1021]; [@b89-ndt-4-1021]). Also when GS appear during the neonatal period, the association with infantile spasms has been described ([@b31-ndt-4-1021]). Only a few reports have described control of GS with medication ([@b53-ndt-4-1021]), in general all the studies have shown that patients with gelastic epilepsy eventually become intractable to medication ([@b9-ndt-4-1021]; [@b89-ndt-4-1021]; [@b48-ndt-4-1021]). However, not all the children progress to intractability. Close to 25% can have a more benign course, without the development of an epileptic encephalopathy and with preserved cognition ([@b4-ndt-4-1021]). Also some studies have reported a more benign course when GS are associated with the Pallister Hal syndrome (PHS). This syndrome is an autosomal dominant inheritable disorder characterized by HHs, polydactyly, laryngeal malformations such as bifid epiglottis, pulmonary segmentation anomalies, imperforate anus, and panhypopituitarism. In the study of [@b8-ndt-4-1021], patients with PHS had less frequent and less severe seizures. It has been estimated that 20% or 25% of patients with PHS have gelastic or other type of seizures ([@b7-ndt-4-1021]). Another 25% of patients can have learning disabilities, developmental delay or mental retardation. On the other hand, patients with PHS have more frequent endocrinologic abnormalities than patients with the syndrome of GS associated with HH, and some of them can develop panhypopituitarism ([@b7-ndt-4-1021]).

The pattern of GS may change over time, especially when patients become adults. Patients can have preservation of frequency and intensity of seizures, but it has been reported that patients can experience disappearance or change in the seizure semiology, experiencing reduction in the gelastic expression and only having a few seconds of laughter (without subjective mirth) to having an "urge to laugh" ([@b4-ndt-4-1021]; [@b39-ndt-4-1021]).

Clinical presentation is different in adult patients. [@b53-ndt-4-1021] described a series of 14 adult patients with GS and HHs and some observations are interesting and different from children. Compared with children, adult patients have a less severe epilepsy syndrome, less severe learning and behavior difficulties, and better occupation and social status. Also, it has been described that adult patients have a better response to surgical treatment and some of them could be controlled with medication ([@b53-ndt-4-1021]).

The presence of cognitive problems in patients with GS has been reported extensively ([@b6-ndt-4-1021]). [@b70-ndt-4-1021] performed comprehensive neuropsychological testing in 13 patients with GS associated with HHs. In this study more than half of the patients displayed deficits in a broad range of cognitive functions, expressed mostly in visual and verbal learning and memory. According to the authors some of the deficits could correlate with disease-related characteristics representing the severity of the epilepsy or the size of the underlying lesion. Other studies have shown similar findings ([@b17-ndt-4-1021]; [@b24-ndt-4-1021]; [@b61-ndt-4-1021]). In general the majority of authors agree that the presence of cognitive dysfunction is more frequent in patients with intractable epilepsy and patients with a long history of seizures ([@b17-ndt-4-1021]; [@b61-ndt-4-1021]). On the other hand some authors have reported that the severity of the cognitive dysfunction is more frequent in patients with large HHs ([@b70-ndt-4-1021]).

Another issue that has been addressed in patients with GS and HH is the presence of psychiatric comorbidity. [@b95-ndt-4-1021] performed structured interviews in 12 patients with GS using as controls, the siblings of patients. Children with GS and HH displayed a higher rate of comorbid psychiatric conditions than controls, these included oppositional defiant disorder (83.3%), attention-deficit/hyperactivity disorder (75%), high rates of conduct disorder (33.3%), speech retardation/learning impairment (33.3%), and anxiety and mood disorders (16.7%). Significant rates of aggression were noted, with 58% of the seizure patients meeting criteria for the affective subtype of aggression and 30.5% having the predatory aggression subtype. Affective aggression was significantly more common (p \< 0.05). Same observations have been reproduced in other series of patients with GS and HH ([@b9-ndt-4-1021]; [@b48-ndt-4-1021]). The risk factors associated with the presence of psychiatric comorbidity are unknown, although some authors suggest that patients with frequent seizures are more predisposed to having this type of comorbidity ([@b67-ndt-4-1021]).

Precocious puberty is a clinical finding that has been reported frequently in patient with GS associated with HH. On the other hand HHs, are not associated with other endocrinologic abnormalities such as growth failure, diabetes insipidus, and hypogonadism, in contrast with other hypothalamic pathologies such as astrocytomas, gliomas and craniopharyngiomas where the frequency is higher. This difference has been explained by the nature of the HH, which is a lesion that has a tendency to displace rather than replace normal structures ([@b27-ndt-4-1021]). The association between central precocious puberty and GS was first described in a child who had a hypothalamic tumor attached to the tuber cinereum and mamillary bodies ([@b20-ndt-4-1021]). [@b29-ndt-4-1021] reported precocious puberty in 3 of 10 patients, [@b9-ndt-4-1021] in 5 of 12 (42%) patients and [@b23-ndt-4-1021] in 5 of 18 (28%). In general, it has been reported between 30% to 40%, but some series have not reported its presence ([@b89-ndt-4-1021]). The pathophysiology of precocious puberty has not been established but some observations have been done. [@b36-ndt-4-1021] analyzed the localization of the HH and the correlation with the clinical symptoms. Ninety-one percent of HHs in patients with isolated precocious puberty revealed a parahypothalamic position without affecting the third ventricle. Some authors have postulated that the mechanism of precocious puberty in patients with HH is related with the activation of endogenous human luteinizing hormone-releasing hormone gene (LHRH) secretion via astroglial-derived factors and induction of hypothalamic pubertal neuroendocrine function by HH secretion of transforming growth factor ([@b37-ndt-4-1021]).

Pathophysiology of gelastic seizures
====================================

Many advances have been achieved regarding the pathophysiology of GS in recent years. Currently it is very well known that the HH is the source for the seizures in these patients. The clinical evidence is as follows; a) the production of laughter and GS from the stimulation of the HH with depth electrodes ([@b10-ndt-4-1021]; [@b38-ndt-4-1021]), b) the recording of ictal fast activity from the HH during GS using intracranial recordings ([@b42-ndt-4-1021]; [@b38-ndt-4-1021]), c) the observation of ictal HH hyperperfusion and hypermetabolism with SPECT and positron emission tomography (PET) ([@b42-ndt-4-1021]; [@b19-ndt-4-1021]; [@b63-ndt-4-1021]), and d) the resolution of seizures with resection, ablation, or irradiation of the HH ([@b76-ndt-4-1021]; [@b80-ndt-4-1021]; [@b43-ndt-4-1021]; [@b73-ndt-4-1021]).

Recent advances have demonstrated intrinsic epileptogenicity of the HH. Two populations of neurons have been shown in HH (small and large neurons). Small neurons are spontaneously firing neurons that express GABA receptors, making them inhibitory in nature ([@b22-ndt-4-1021]). The second group are large, pyramidal like neurons that hyper-polarize in repose to GABA agonist. It is proposed that the chronic epileptogenesis of HH is related with the cluster of small GABAergic neurons, firing action potentials spontaneously and synapse onto the large pyramidal neurons, synchronizing the activity of the large output neurons ([@b97-ndt-4-1021], [@b96-ndt-4-1021]). Alternative theories suggest that the small neurons could have similarities in morphology and function with neurons from lesions of cortical dysplasia, being potentially epileptogenic ([@b22-ndt-4-1021]). Also the possibility of ephaptic mechanisms, possibly trough gap junction and astroglial involvement has been suggested ([@b22-ndt-4-1021]).

Electrophysiology and type of seizures in patients with gelastic seizures associated with HH
============================================================================================

Scalp EEG is very limited in order to show epileptiform activity due to the deep localization of the lesion and the complex connections of the HHs ([@b48-ndt-4-1021]). In early stages of the illness, the interictal EEG usually is normal ([@b4-ndt-4-1021]; [@b54-ndt-4-1021]). After some years of evolution, electrographic changes consistent with lobar involvement may become apparent ([@b26-ndt-4-1021]). The EEG in many patients shows multifocal epileptiform activity ([@b40-ndt-4-1021]). Also in children it is possible to see ictal and interictal generalized polyspike waveform discharges ([@b26-ndt-4-1021]).

Complex partial seizures are frequently seen in patients with GS associated with HHs. In some patients the distinction between GS and complex partial seizures can be difficult to ascertain on history and on video analysis ([@b33-ndt-4-1021]). Epigastric discomfort, fear, oral and bimanual automatisms, axial movements and complex bi-pedal movements are frequently reported during complex partial seizures in patients with HH ([@b42-ndt-4-1021]; [@b48-ndt-4-1021]). [@b91-ndt-4-1021] reported 6 patients that were misdiagnosed with gastroesophageal reflux; all of them had GS associated with HHs. The symptoms in this group of patients included regurgitation, irritability, arching, choking, and apnea. Reported focal motor features including head and eye version, asymmetric tonic posturing, tonic or clonic lower facial contraction, and limb jerking. Some selected series have reported typical temporal lobe seizures with electrographic changes in the temporal area and where the consideration of a temporal lobectomy was performed ([@b10-ndt-4-1021]). EEG in patients with complex partial seizures can show intermittent focal slowing or epileptiform activity ([@b47-ndt-4-1021]). Epileptiform activity can be present over the frontal or the temporal region ([@b10-ndt-4-1021]). In some patients the ictal EEG during complex partial seizures may show diffuse attenuation, but this is followed by localized or regionalized fast rhythms or spike wave ([@b10-ndt-4-1021]). It has been demonstrated that the behavioral and motor manifestations constituting the nongelastic component and the complex partial seizures in these patients represent spread of seizure activity from the HH to specific frontal, temporal or other cortical regions ([@b44-ndt-4-1021]). In fact, some authors have shown that cortical resections are usually not successful in order to control the seizures ([@b10-ndt-4-1021]).

The presence of generalized tonic-clonic seizures (GTCS) has been reported commonly in patients with GS associated with HH. Large series report a frequency of GTCS of approximately 70% ([@b60-ndt-4-1021]), although the frequency is lower in nonsurgical series and maybe in adult patients ([@b53-ndt-4-1021]; [@b54-ndt-4-1021]). In series with long-standing follow up, it has been shown that usually GTCS come after some years of having GS and complex partial seizures and their development is accompanied with more widespread EEG abnormalities and neurobehavioral disturbances ([@b6-ndt-4-1021]; [@b26-ndt-4-1021]; [@b89-ndt-4-1021]). In patients with GTCS the EEG frequently shows an increase in the amount of interictal generalized spike wave activity during wakefulness and sleep and it is possible to see secondary bilateral synchrony. Also presence of continuous slow spike wave, paroxysmal fast activity and electrodecremental events, in a similar way as patients with Lennox-Gastaut Syndrome has been reported ([@b26-ndt-4-1021]). The pathogenesis of GTCS and EEG abnormalities in patients with HH is unknown. The findings supporting a cortical involvement related with cerebral dysgenesis are controversial ([@b6-ndt-4-1021]), and the favorable results with HH surgery point to the possibility of seizure propagation from the HH to the cortex. However some reports using depth electrodes have shown that during tonic seizures, diffuse cortical fast activity can be seen, with no prior activity in the HH ([@b38-ndt-4-1021]). Some authors have mentioned that the development of GTCS and generalized EEG abnormalities may represent secondary epileptogenesis or a kindling effect in the neocortex, as a consequence of repetitive epileptiform discharges from the HH to the cerebral cortex ([@b39-ndt-4-1021]; [@b55-ndt-4-1021], [@b56-ndt-4-1021]). Over the years it has been considered that the neocortex in patients with GS and HHs becomes a secondary focus to the primary source of seizures in the HH, with potential postoperative resolution in patients who have not reached the irreversible, independent stage ([@b26-ndt-4-1021]).

Determinants of clinical manifestations
=======================================

Some associations have been shown between the localization of the HH and the clinical profile, although these are not constant. For example, some studies have shown that size is important in order to determine the seizure severity. In the series of [@b54-ndt-4-1021] patients with HH between 4 to 10 mm had late onset seizures more frequently than patients with smaller HH. [@b25-ndt-4-1021] performed the clinical correlation between clinical findings and the size and localization of HH. HHs associated with epilepsy had more ventricular attachment and with connection to one or the two mammillary bodies. On the other hand, hamartomas associated with only precocious puberty were more frequently related with the tuber cinereum (predominantly intraventricular versus predominantly interpeduncular) ([@b25-ndt-4-1021]). Some studies have suggested that small HHs can have less severe seizures, less cognitive problems and a lower frequency of precocious puberty ([@b90-ndt-4-1021]; [@b88-ndt-4-1021]). Also the asymmetry of HH attachment can correlate with asymmetries in clinical seizure characteristics ([@b33-ndt-4-1021]).

Status gelasticus
=================

The term status gelasticus was coined by [@b63-ndt-4-1021]. He described a case report of a patient with continuous GS associated with a HH. The patient was treated successfully with carbamazepine. After this description other reports have described this rare clinical phenomenon associated with HHs ([@b58-ndt-4-1021]), and recently [@b69-ndt-4-1021] reported a patient with intractable symptomatic focal epilepsy where a status gelasticus was triggered by levetiracetam.

Treatment of patients with gelastic seizures and hypothalamic hamartomas
========================================================================

GS are characteristically refractory to medical treatment and the progressing epileptic process eventually leads to deterioration of cognitive and behavioral function ([@b62-ndt-4-1021]). Despite the use of higher dose and several combinations of antiepileptic drugs (AEDs), seizure freedom or good seizure control is rarely achieved in this group of patients ([@b33-ndt-4-1021]). Patients with intractable epilepsy associated with HHs should be investigated with intracranial recording in order to clarify the seizure onset in the HH. In many cases extrahypothalamic coverage should be performed to evaluate spread of seizures and potential extratemporal onset ([@b10-ndt-4-1021]). Currently it is recognized that the best treatment in these patients is the ablation of the HH. This can be done with different procedures including surgery and nonsurgical treatments such as radiosurgery ([@b10-ndt-4-1021]).

Different surgical procedures have been attempted to control GS in patients with HHs. Focal cortical resections and callosotomies were performed unsuccessfully in the mid 90s based on intracranial EEG monitoring results and the presence of drop attacks in patients with intractable epilepsy associated to HHs ([@b10-ndt-4-1021]). Vagal nerve stimulation has been used, but the results are equivocal ([@b57-ndt-4-1021]). Evidence about the role of the HH in the genesis of GS has promoted the concept of HH resection, ablation, or disconnection as surgical goals.

The location and anatomical features of HHs have shown correlation with the clinical presentation and the appropriate selection of the surgical approach. [@b94-ndt-4-1021] classified HHs as pedunculated or type I and sessile or type II. Pedunculated HHs have a narrow attachment to the tuber cinereum (type Ia) or the angle between the tuber cinereum and a mamillary body (type Ib). These HHs do not disturb the hypothalamic region and predominantly produce precocious puberty. Sessile HHs have a broad attachment to the floor of the third ventricle and the mamillary bodies. This type of HHs may produce distortion of the third ventricle and are commonly associated with GS. [@b2-ndt-4-1021] proposed a newer classification of HHs based on MRI characteristics. They described two categories, parahypothalamic and intrahypothalamic types, which correspond to pedunculated and sessile hamartomas, respectively.

Surgical resection of HHs has been performed by approaches that reach the lesion from below or from above. Surgical approaches from below are performed by a pterional or frontotemporal craniotomies that access the HH through a transsylvian, subtemporal, transfrontal or subfrontal/lamina terminalis corridor ([@b47-ndt-4-1021]; [@b94-ndt-4-1021]; [@b45-ndt-4-1021]; [@b52-ndt-4-1021]; [@b62-ndt-4-1021]). These approaches were initially used because most of the neurosurgeons are more confident with them and they offer a shorter route to reach HHs. During these approaches, the surgeon dissects delicate vascular and neuroendocrine structures, thus surgical complications are not unusual and include stroke, third nerve paresis, syndrome of inappropriate antidiuretic hormone secretion, and hyperphagia ([@b62-ndt-4-1021]). Although surgical approaches from below are suitable to remove pedunculated HHs, they have technical limitations to obtain satisfactory resection of sessile HHs which are associated to GS. [@b45-ndt-4-1021] reviewed the surgical literature and reported that 42.9% of patients undergoing craniotomies improve or obtain seizure freedom. These unsuccessful results created the need to find different surgical approaches that could achieve better resection of the intraventricular component of sessile HHs and offer better seizure control.

[@b80-ndt-4-1021] proposed to reach the HH from above by performing a transcallosal-interforniceal approach which had been used previously to resect lesions affecting the third ventricle ([@b1-ndt-4-1021]). The transcallosal-interforniceal approach allows disclosing the entire intraventricular component of the HH and achieves complete or nearly complete (\>95%) excision of sessile HH ([@b1-ndt-4-1021]). This surgical approach has shown a significant better seizure control than previous approaches from below. A recent publication from Royal Children's Hospital in Melbourne and the Barrow Neurological Institute in Phoenix, AZ reported that 52% to 54% of the patients are seizure free and 24% to 35% have \>90% seizure reduction ([@b21-ndt-4-1021]). [@b34-ndt-4-1021] report the seizure outcome of 29 patients with a mean follow up of 30 months using this approach. In this study 15 patients were seizure free, 7 patients had \>90% reduction in seizure frequency, 3 had 55% to 80% reduction and 4 had \<40% reduction. The fornix and mammillary body may be injured during the transcallosal-interforniceal approach, explaining an 8% to 14% risk of short-term memory impairment. Although it may be a permanent deficit it seems tolerable considering the overall improvement of cognitive function ([@b21-ndt-4-1021]; [@b78-ndt-4-1021]). Other complications reported with this procedure that have been reported are third nerve paresis, hemiparesis, appetite stimulation and weight gain, transient hypersomnolence and hyperthermia, and transient endocrine abnormalities such as hypothyroidism and diabetes insipidus ([@b78-ndt-4-1021]).

[@b16-ndt-4-1021] have considered that surgical disconnection, instead of surgical resection of the HH, is an effective and safe alternative. The intrinsic epileptogenic activity and stable nature of the HH support the rationale of blocking the epileptic spreading pathway to control GS. Depth electrodes inserted into the HH have shown immediate intraoperative disappearance of epileptic discharges from the HH, during endoscopic disconnection ([@b12-ndt-4-1021]). The disconnection is performed by endoscopic and/or pterional approach depending on the plane of insertion of the HH on the hypothalamus ([@b16-ndt-4-1021]). [@b68-ndt-4-1021] reported a series of 33 patients who underwent disconnection by pterional and/or robot-assisted endoscopic approach. All patients except one improved clinically. Seizure freedom (Engel Class 1) was seen in 16 patients (48.5%) and significant improvement (Engel Classes 2 and 3) in 16 patients (48.5%). Patients who only required endoscopic disconnection had better control of seizures; thus, 90% of them were seizure free (Engel Class 1) and 10% showed significant improvement (Engel Class 3).

Stereotactic radiofrequency thermocoagulation of the HH has been used as a minimally invasive surgical approach. A small burr-hole or twist-drill opening is required to allow stereotactic placement of the stimulating/lesioning electrode ([@b64-ndt-4-1021]). [@b42-ndt-4-1021] reported total seizure control in a single case during a 20-month follow up period. The size of the HH is an important criterion to select the patient, as better seizure control has been found in small lesions. [@b35-ndt-4-1021] recently published a series of five patients with small HHs and intractable GS. All of them had HHs less than 10 mm in diameter and total gelastic seizure control was obtained in four patients. Sterotactic radiofrequency thermocoagulation is a safe procedure and despite of some postoperative transitory hypothalamic symptoms, no permanent neurologic deficits have been reported ([@b42-ndt-4-1021]; [@b64-ndt-4-1021]; [@b35-ndt-4-1021]).

The first case of a HH successfully treated with gamma knife surgery (GKS) was reported by [@b3-ndt-4-1021]. [@b75-ndt-4-1021] enrolled 60 patients with HH treated with gamma knife between 1999 and 2005. All the patients were treated with gamma knife in a prospective multicentre trial. In this trial 59.2% of the patients had an excellent result with a dramatic behavioral and cognitive improvement, 37% are seizure free or have only rare nondisabling seizures in 22.2% ([@b74-ndt-4-1021]). Other small series also suggested the efficacy of gamma knife in the treatment of patients with GS associated with HH ([@b5-ndt-4-1021]; [@b84-ndt-4-1021]; [@b49-ndt-4-1021]). Despite the popularity of this therapy the main disadvantage of the procedure is the delay of its effect. In the majority of patients, seizures start to decrease around 6 months after the procedure; however there is a great variability in the timing of the response ([@b80-ndt-4-1021]). For this reason some authors advised the surgical approach for patients with intractable epilepsy and severe behavior abnormalities. Other disadvantages of the procedure are the lower seizure outcome compared with the transcallosal approach and the possibility of radiation damage to the surrounding hypothalamus and visual pathways. Finally [@b74-ndt-4-1021] and other authors have suggested the use of gamma knife in patients with residual lesions after surgery. In [Tables 1](#t1-ndt-4-1021){ref-type="table"}, [2](#t2-ndt-4-1021){ref-type="table"}, and [3](#t3-ndt-4-1021){ref-type="table"} we summarize all the studies (case reports, not included) reporting different outcomes in patients with GS associated with HHs that have received different treatments.

Conclusions
===========

HHs are rare tumors associated with the triad of gelastic epilepsy, precocious puberty, and developmental delay. HHs are diagnosed more frequently during childhood and eventually the majority of the patients develop intractable epilepsy. GS is the first type of seizure that these patients develop, although other type of seizures are frequently present such as complex partial seizures, generalized tonic-clonic seizures, drop attacks and infantile spasms. Progressive cognitive deficits and the presence of important psychiatric comorbidity are widely described. When the syndrome appears in adults, the prognosis may be better, with less severe epilepsy and better neurophysiological outcomes. Due to the intractability of these patients, many of them will require intracranial investigations in order to have surgery. The surgical procedure that has shown the best seizure outcome is the transcallosal approach but other nonsurgical procedures such as radiosurgery are gaining popularity because of good results.
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###### 

Studies using gamma knife to treat patients with gelastic seizures

  Authors             Number of patients   Age range (Mean, median)   Follow up                     \% seizure free                                             Precocious puberty
  ------------------- -------------------- -------------------------- ----------------------------- ----------------------------------------------------------- --------------------
  [@b49-ndt-4-1021]   4                    5--29 Y                    22 months                     3 patients had some improvement                             No data
  [@b74-ndt-4-1021]   27                   3--50 Y (19.2, 17.2)       36 months                     37%                                                         74%
  [@b5-ndt-4-1021]    3                    3 and 12 and 15 Y          30--50 months                 0% but all patients had significant decrease in frequency   33%
  Regis et al 2005    10                   1--32 Y (14, 13.5)         \>12 month median 28 months   40%                                                         30%

###### 

Studies using radiosurgery/stereotactic radiation to treat patients with gelastic seizures

  Authors             Number of patients   Age range, Mean, or median      Follow up   \% seizure free                          Precocious puberty
  ------------------- -------------------- ------------------------------- ----------- ---------------------------------------- --------------------
  [@b83-ndt-4-1021]   15                   3--20 Y (mean 13.9 Y)           36 months   20%                                      20%
  [@b71-ndt-4-1021]   14                   15--43 Y (mean 15.4 ± 10.5 Y)   3 months    0% free but 50% reduction of frequency   No data
  [@b82-ndt-4-1021]   6                    9--31 Y (mean 17 Y)             12 months   33%                                      33%

###### 

Studies using neurosurgery to treat patients with gelastic seizures

  Authors                    Number of patients   Age range (mean, median)       Procedure                                                                                              Average procedure length   Follow up                                \% Seizure free                      Precocious puberty
  -------------------------- -------------------- ------------------------------ ------------------------------------------------------------------------------------------------------ -------------------------- ---------------------------------------- ------------------------------------ --------------------
  [@b77-ndt-4-1021]          44                   8 months--44 Y, (15 Y, 10 Y)   Endoscopic via lateral ventricle through foramen on Monroe                                             60--90 min                 12 months                                49%                                  No data
  [@b60-ndt-4-1021]          26                   2.1--24.2 Y (mean 10 Y)        Transcallosal                                                                                          5--6 h                     13--28 (20.3) months                     54%                                  42%
  [@b77-ndt-4-1021]          44                   8 months--55 Y (15 Y, 10 Y)    Endoscopic via lateral ventricle through foramen on Monroe                                             \~ 90 min                  At least 3 months                        30%                                  No data
  [@b79-ndt-4-1021]          45                   2.9--33 Y (mean 11.3 Y)        Anterior transcallosal transseptal interforniceal approach                                             Not reported               8--66 months                             52%                                  No data
  [@b34-ndt-4-1021]          29                   4--23 Y (mean 10 Y)            Transcallosal                                                                                          Not reported               12--70 (mean 30) months                  52%                                  65%
  [@b26-ndt-4-1021]          12                   4--17 Y, (9 Y, 9.16 Y)         Transcallosal, interforniceal, transventricular                                                        Not reported               13--61 (mean 29) months                  58%                                  No data
  Dellande and Fohlen 2003   17                   9 months--32 Y                 One patient total removal(approach not mentioned), 14 pterional route and 1 endoscopic disconnection   31 min (SD 20 min)         Mean 18.6 months (8 days to 43 months)   47%                                  29%
  [@b62-ndt-4-1021]          13                   2--33 Y                        Pterional, or subfrontal                                                                               Not reported               1.5 to 6 years (mean: 3.4 years)         15%                                  31%
  [@b52-ndt-4-1021]          8                    1 week--10 Y                   Right fronto-temporal craniotomies                                                                     Not reported               17 months to 19 year (mean 5 years)      Better control but 0% seizure free   75%
  [@b80-ndt-4-1021]          5                    4--13 Y                        Transcallosal                                                                                          Not reported               9--37 (mean 24 months)                   60%                                  No data
